Rayca’s AI rapidly designs, screens and optimizes thousands of therapeutic candidates for hard-to-drug targets, leading our owned and partnered therapeutic pipelines from concept to IND-approval. Rayca's platform is a closed-loop process where each data point—from screening, in vitro testing, or preclinical validation—feeds back into the AI models to continuously improve future drug designs.
At Rayca Precision, we decode the complexity of disease biology using advanced multi-omics analysis powered by a secured, integrated bioinformatics platform, in silico virtual screenings, and predictive modeling to accelerate drug discovery. Our platform integrates potency matrices, dynamic molecular simulations, and high-resolution structural modeling to design highly optimized drug candidates. We specialize in creating a diverse range of therapeutic modalities, including small molecules, cyclic and linear peptides, peptidomimetics, bispecific antibodies, and RNA-based drugs. Leveraging best in class algorithms, we perform large-scale virtual screenings across uncharted chemical and biomolecular spaces to uncover cryptic binding pockets and novel mechanisms of action.
Rayca merges computational sophistication with iterative experimental validation. Using proprietary in silico workflows, we optimize molecular properties such as binding affinity, selectivity, and pharmacokinetics, all while minimizing off-target effects. For biologics, our epitope mapping and protein engineering pipelines refine binding interfaces to achieve superior stability and reduced immunogenicity. For small molecules and peptides, we explore chemical libraries at scale, balancing ADMET properties with therapeutic potency. From gene-editing tools to peptidomimetics, every candidate we design is rigorously tested against predictive and experimental benchmarks. Rayca delivers therapies that redefine possibilities in oncology, immunotherapy, and rare diseases.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 166 Geary St, San Francisco,ca 94108,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://rayca.ai/
- Keywords
- Computational Biology, AI Drug Design, Drug Discovery, Computational Drug Design, NGS Data Analysis, Multi-Omics, Bioinformatics, AI Drug Discovery, Peptidomimetics, Antibody Drugs, ADCs, CAR T-Cell Therapy, Protein Design, Small Molecule, Rare Diseases, Oncology, Immuno-Oncology, Immunotherapy.
- HQ
- San Francisco, CA
Rayca Precision Questions
Rayca Precision's website is https://rayca.ai/
Rayca Precision's LinkedIn profile is https://www.linkedin.com/company/raycaai
Rayca Precision has
17 employees.
View email and phone details for 17
employees at Rayca Precision.
Rayca Precision's industry is
Biotechnology Research
Rayca Precision's top competitors are
Lifebit,
Asian American Center Of Frederick,
Zetta Genomics Ltd,
Eavono,
Build Umass,
Nonacus Clinical Services (Formerly Informed Genomics),
Qiagen,
Appvity,
Voll Recruiting,
Cian Diagnostics.
Rayca Precision's categories are Biotechnology Research
Rayca Precision's founding year is 2022
